<DOC>
	<DOCNO>NCT01347580</DOCNO>
	<brief_summary>The aim study determine whether initiation ticagrelor early ambulance set lead rapid reperfusion infarct-related artery therefore facilitate Percutaneous Coronary Intervention ( PCI ) optimize outcome patient . The study ass efficacy safety pre-hospital compare in-hospital administration ticagrelor co-administration aspirin , restore blood flow occlude heart artery improve myocardial perfusion patient suffer myocardial infarction plan PCI . Patients randomise either one 2 arm : re-hospital ticagrelor arm : Patients receive load dose 180 mg ticagrelor pre-hospital administration placebo in-hospital administration . In-hospital ticagrelor arm : Patients receive placebo pre-hospital administration 180 mg ticagrelor load dose in-hospital administration . Patients initially manage ambulance physician/personnel pre hospital setting . They transfer Catheterization room undergo PCI . After administration load dose ticagrelor ( double blind ) , patient continue ticagrelor 90 mg bid follow study 30 day post randomisation .</brief_summary>
	<brief_title>A 30 Day Study Evaluate Efficacy Safety Pre-hospital vs. In-hospital Initiation Ticagrelor Therapy STEMI Patients Planned Percutaneous Coronary Intervention ( PCI )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Women must childbearing potential ( 1 year postmenopausal surgically sterile ) . Symptoms acute MI 30 min less 6 hour New persistent STsegment elevation â‰¥ 1 mm two contiguous electrocardiogram ( ECG ) lead . Expected time 1st PCI balloon inflation hospital , qualify ECG 120 minute Contraindication ticagrelor ( refer SmPC ) Concomitant medication may increase risk bleed [ e.g non steroidal antiinflammatory drug ( NSAIDs ) , oral anticoagulant / fibrinolytics , plan administer 24 hour randomization ] Any following condition absence function implant pacemaker : know SSS , second third degree AVB , document syncope suspect bradycardic origin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Heart attack</keyword>
	<keyword>heart disease</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>stroke</keyword>
	<keyword>reperfusion</keyword>
	<keyword>pre hospital setting</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>